Low‐dose colchicine vs placebo
Pain ‐ not reported · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
4,760 questions · 8,065 findings · 1,036 reviews
No studies found 1,686 · 20.9%GRADE not reported 675 · 8.4%Very low 1,953 · 24.2%Low 2,048 · 25.4%Moderate 1,296 · 16.1%High 407 · 5%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Low‐dose colchicine vs placebo
Participant global assessment of treatment success: proportion with 50% or greater decrease in pain score from baseline ‐ 32 to 36 hours · acute gout
Low‐dose colchicine may leads to higher participant global assessment of treatment success: proportion with… compared with placebo (low certainty).
1 finding from 1 review
- RR 2.43 [1.05, 5.64]1 study · 103 participantsLow
Low‐dose colchicine vs NSAIDs
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · acute gout
1 finding from 1 review
- no estimate extracted1 study · 399 participantsLow
Low‐dose colchicine vs NSAIDs
Global assessment of treatment success · acute gout
Low‐dose colchicine showed no clear difference in participant global assessment of treatment success: Completely… compared with NSAIDs (low certainty).
1 finding from 1 review
- RR 0.97 [0.82, 1.15]1 study · 399 participantsLow
Low‐dose colchicine vs NSAIDs
Reduction of inflammation ‐ not measured · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs NSAIDs
Function of target joint ‐ not measured · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs NSAIDs
Serious adverse events · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs NSAIDs
Number of participants reporting an adverse event · acute gout
Low‐dose colchicine showed no clear difference in total number of participants reporting adverse events compared with NSAIDs (low certainty).
1 finding from 1 review
- RR 1.07 [0.88, 1.29]1 study · 399 participantsLow
Low‐dose colchicine vs NSAIDs
Withdrawals due to adverse events · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs placebo
Reduction of inflammation ‐ not measured · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs placebo
Function of target joint ‐ not measured · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐dose colchicine vs placebo
Serious adverse events · acute gout
1 finding from 1 review
- no estimate extracted1 study · 133 participantsGRADE not reported
Low‐dose colchicine vs placebo
Total adverse events · acute gout
Low‐dose colchicine showed no clear difference in total adverse events compared with placebo (low certainty).
1 finding from 1 review
- RR 1.32 [0.68, 2.56]1 study · 103 participantsLow
Low‐dose colchicine vs placebo
Withdrawals due to adverse events · acute gout
1 finding from 1 review
- no estimate extracted1 study · 133 participantsGRADE not reported
Lipid‐lowering agent vs placebo or no treatment
Outcomes (measurement/time point) · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Lipid‐lowering agent vs placebo or no treatment
Neurological impairment · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Lipid‐lowering agent vs placebo or no treatment
Ipsilateral major or disabling stroke · asymptomatic carotid stenosis
Lipid‐lowering agent showed no clear difference in ipsilateral major or disabling stroke (only reported for two… compared with placebo or no treatment (low certainty).
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyRR 0.36 [0.09, 1.53]5 studies · 2235 participantsLow
Lipid‐lowering agent vs placebo or no treatment
Stroke‐related mortality · asymptomatic carotid stenosis
Lipid‐lowering agent showed no clear difference in stroke‐related mortality (only reported for one study: CT scan, MRI… compared with placebo or no treatment (low certainty).
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyRR 0.25 [0.03, 2.29]2 studies · 1366 participantsLow
Lipid‐lowering agent vs placebo or no treatment
Major bleeding · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Lipid‐lowering agent vs placebo or no treatment
Progression of carotid stenosis · asymptomatic carotid stenosis
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found